Cohort profile: the Health and Memory Study (HMS): a dementia cohort linked to the HUNT study in Norway
Sverre Bergh1, Jostein Holmen2, Jessica Gabin2
1Centre for Old Age Psychiatric Research, Innlandet Hospital Trust, Ottestad, Norway, HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Norway, Namsos Hospital, Nord-Trøndelag Health Trust, Namsos, Norway, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger, Norway, Department of Geriatrics, St Olav Hospital, University Hospital of Trondheim, Norway and Division of Mental Health, Norwegian Institute of Public Health, Oslo, Norway sverre.bergh@sykehuset-innlandet.no.
Abstract:
The aim of the Health and Memory Study (HMS) of Nord-Trøndelag, Norway, was primarily to establish a database suitable as basis for a large number of studies on dementia. Data from the HMS study were collected via questionnaires and examinations during the period from 1995 to 2011. The dementia panel consists of 620 participants residing in nursing homes and 920 participants referred to memory clinics of Nord-Trøndelag. Data from this dementia panel may be linked to the Nord-Trøndelag Health Study (the HUNT study), three large population based health surveys that took place in 1984-86 (HUNT1), 1995-97 (HUNT2) and 2006-08 (HUNT3). Data collection is complete and the participation rate in the HUNT1 for patients diagnosed with dementia was 86%. The sub-studies in the HMS are focused on examining risk factors, caregiver burden, healthcare consumption and economic consequences of treating and having dementia. Researchers interested in the HMS study are invited to contact HUNT at hunt@medisin.ntnu.no.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Related Concept Videos
Longitudinal Research
Huntington Disease l: Introduction
Longitudinal Studies
Alzheimer Disease l: Introduction
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
